Get the Stockscreener App
39.70
0.53%
-0.21
After Hours:
39.70
Qiagen Nv Stock (QGEN) Latest News
Liquid Biopsy Market Worth US$11.3 billion at a robust CAGR of 11.9% | MarketsandMarkets™. - GlobeNewswire Inc.
Qiagen N.V.: Some Clarity Needed Before Buying The Dip (NYSE:QGEN) - Seeking Alpha
Genetic Testing Market Future Business Opportunities - openPR
AlphaValue/Baader Europe Upgrades Qiagen to Buy, Trims PT -February 24, 2025 at 07:17 am EST - Marketscreener.com
Qiagen (NYSE:QGEN) Stock Rating Lowered by Baird R W - MarketBeat
Qiagen, Bio-Techne downgraded at Baird amid NIH funding concerns - MSN
QIAGEN NV : Berenberg remains its Buy rating -February 21, 2025 at 03:41 am EST - Marketscreener.com
Baird Downgrades Qiagen N.V. (BIT:1QGEN) - Nasdaq
Baird Downgrades Qiagen N.V. (QGEN) - MSN
Baird Downgrades Qiagen N.V. (BRSE:QGEN) - Nasdaq
This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Baird Downgrades Qiagen N.V. (LSE:0RLT) - Nasdaq
Qiagen downgraded to Neutral from Outperform at Baird - TipRanks
QIAGEN opens new data center in Melbourne - MSN
Are Qiagen N.V.'s (NYSE:QGEN) Mixed Financials Driving The Negative Sentiment? - Simply Wall St
Institutional owners may take dramatic actions as Qiagen N.V.'s (NYSE:QGEN) recent 5.6% drop adds to one-year losses - Yahoo Finance
QIAGEN NV : Deutsche Bank keeps its Buy rating -February 14, 2025 at 07:01 am EST - Marketscreener.com
William Blair Issues Negative Forecast for Qiagen Earnings - MarketBeat
Qiagen (NYSE:QGEN) Reaches New 12-Month Low Following Analyst Downgrade - MarketBeat
QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region - br.ADVFN.com
QIAGEN opens new data center in Melbourne By Investing.com - Investing.com Nigeria
Major Bioinformatics Milestone: QIAGEN's 8th Global Data Hub Powers Asia-Pacific Healthcare Revolution - StockTitan
Companion Diagnostics Market Trends 2019-2024 and Forecast to 2034 - GlobeNewswire Inc.
QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation - br.ADVFN.com
Qiagen (NYSE:QGEN) Shares Gap DownShould You Sell? - MarketBeat
Qiagen (NYSE:QGEN) Given New $48.00 Price Target at UBS Group - MarketBeat
Qiagen at low since July, Merck weakUSA cuts research -February 10, 2025 at 05:28 am EST - Marketscreener.com
Qiagen (NYSE:QGEN) Announces Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Qiagen (NYSE:QGEN) Updates Q1 2025 Earnings Guidance - MarketBeat
Qiagen (NYSE:QGEN) Updates FY 2025 Earnings Guidance - MarketBeat
Qiagen Exceeds 2024 Financial Outlook with Solid Growth - TipRanks
Qiagen targets 4% CER sales growth for 2025 with key portfolio advancements - MSN
QIAGEN Q4 Earnings Miss, Stock Crashes, Margins Expand - MSN
QIAGEN NV : DZ Bank maintains a Buy rating -February 07, 2025 at 09:42 am EST - Marketscreener.com
Qiagen N.V. (NYSE:QGEN) Q4 2024 Earnings Call Transcript - Insider Monkey
Sequencing Reagents Industry Eyes $15.84 Billion Valuation by 2030Thermo Fisher Scientific, Abzena, Illumina, QIAGEN, and Pacific Biosciences of California Lead the Competition - Yahoo Finance
Qiagen (NYSE:QGEN) Receives $50.07 Consensus Price Target from Brokerages - MarketBeat
UBS Adjusts QIAGEN Price Target to $48 From $50, Maintains Neutral Rating -February 07, 2025 at 11:23 am EST - Marketscreener.com
QIAGEN Reports Solid Growth and Exceeds 2024 Outlook - TipRanks
1.50%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):